表紙
市場調查報告書

胃癌:開發中產品分析

Gastric Cancer - Pipeline Review, H2 2019

出版商 Global Markets Direct 商品編碼 232773
出版日期 內容資訊 英文 2044 Pages
訂單完成後即時交付
價格
Back to Top
胃癌:開發中產品分析 Gastric Cancer - Pipeline Review, H2 2019
出版日期: 2019年12月16日內容資訊: 英文 2044 Pages
簡介

胃癌是胃內膜發生的惡性腫瘤,其徵兆及症狀有倦怠感,腹痛,嘔吐,體重減少,飯後的飽漲感,胃部發熱,消化不良等。罹患胃癌的原因有抽煙、惡性貧血、胃部息肉、感染胃幽門桿菌,家族病史等。

本報告提供胃癌治療藥的開發中產品概要和臨床實驗的各階段產品概要,提供您主要企業簡介,藥物簡介,開發中產品的最新趨勢等資訊。

簡介

胃癌 - 概要

胃癌 - 治療藥的開發

胃癌 - 治療藥的評估

胃癌的治療藥開發企業

藥物簡介

胃癌 - 暫停中的計劃

胃癌 - 開發中止的產品

胃癌 - 產品開發的里程碑

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC11702IDB

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Pipeline Review, H2 2019, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling bloated after eating, heartburn and indigestion. Risk factors include smoking, pernicious anemia, stomach polyps, infection with helicobacter pylori and family history of stomach cancer. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Gastric Cancer - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Gastric Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 2, 14, 107, 158, 9, 143, 20 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 11, 8, 1, 9 and 4 molecules, respectively.

Gastric Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Gastric Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Gastric Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Gastric Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Gastric Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Gastric Cancer (Oncology)

Reasons to buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Gastric Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Gastric Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Introduction
  • Gastric Cancer - Overview
  • Gastric Cancer - Therapeutics Development
  • Gastric Cancer - Therapeutics Assessment
  • Gastric Cancer - Companies Involved in Therapeutics Development
  • Gastric Cancer - Drug Profiles
  • Gastric Cancer - Dormant Projects
  • Gastric Cancer - Discontinued Products
  • Gastric Cancer - Product Development Milestones
  • Appendix

List of Tables

  • Number of Products under Development for Gastric Cancer, H2 2019
  • Number of Products under Development by Companies, H2 2019
  • Number of Products under Development by Universities/Institutes, H2 2019
  • Number of Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
  • Products under Development by Companies, H2 2019
  • Products under Development by Universities/Institutes, H2 2019
  • Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
  • Number of Products by Stage and Target, H2 2019
  • Number of Products by Stage and Mechanism of Action, H2 2019
  • Number of Products by Stage and Route of Administration, H2 2019
  • Number of Products by Stage and Molecule Type, H2 2019
  • Gastric Cancer - Pipeline by 3SBio Inc, H2 2019
  • Gastric Cancer - Pipeline by AbbVie Inc, H2 2019
  • Gastric Cancer - Pipeline by AbClon Inc, H2 2019
  • Gastric Cancer - Pipeline by AbGenomics International Inc, H2 2019
  • Gastric Cancer - Pipeline by Abion Inc, H2 2019
  • Gastric Cancer - Pipeline by ABL Bio Inc, H2 2019
  • Gastric Cancer - Pipeline by Abpro Corp, H2 2019
  • Gastric Cancer - Pipeline by AD Pharmaceuticals Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2 2019
  • Gastric Cancer - Pipeline by ADC Therapeutics SA, H2 2019
  • Gastric Cancer - Pipeline by Advenchen Laboratories LLC, H2 2019
  • Gastric Cancer - Pipeline by Akeso Biopharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Alkermes Plc, H2 2019
  • Gastric Cancer - Pipeline by Allist Shanghai Pharmaceutical Technology Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Alteogen Inc, H2 2019
  • Gastric Cancer - Pipeline by Altor Bioscience LLC, H2 2019
  • Gastric Cancer - Pipeline by Ambrx Inc, H2 2019
  • Gastric Cancer - Pipeline by amcure GmbH, H2 2019
  • Gastric Cancer - Pipeline by Amgen Inc, H2 2019
  • Gastric Cancer - Pipeline by Andes Biotechnologies, H2 2019
  • Gastric Cancer - Pipeline by Anew Oncology Inc, H2 2019
  • Gastric Cancer - Pipeline by Antikor Biopharma Ltd, H2 2019
  • Gastric Cancer - Pipeline by Apollomics Inc, H2 2019
  • Gastric Cancer - Pipeline by Apotex Inc, H2 2019
  • Gastric Cancer - Pipeline by Arbele Ltd, H2 2019
  • Gastric Cancer - Pipeline by Argonaut Therapeutics Ltd, H2 2019
  • Gastric Cancer - Pipeline by Arromax Pharmatech Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Asana BioSciences LLC, H2 2019
  • Gastric Cancer - Pipeline by Ascelia Pharma AB, H2 2019
  • Gastric Cancer - Pipeline by Ascenta Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by AskAt Inc, H2 2019
  • Gastric Cancer - Pipeline by Aslan Pharmaceuticals Ltd, H2 2019
  • Gastric Cancer - Pipeline by Astellas Pharma Inc, H2 2019
  • Gastric Cancer - Pipeline by AstraZeneca Plc, H2 2019
  • Gastric Cancer - Pipeline by Atara Biotherapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Aurigene Discovery Technologies Ltd, H2 2019
  • Gastric Cancer - Pipeline by Aurora BioPharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Basilea Pharmaceutica Ltd, H2 2019
  • Gastric Cancer - Pipeline by Bayer AG, H2 2019
  • Gastric Cancer - Pipeline by BeiGene Ltd, H2 2019
  • Gastric Cancer - Pipeline by Beijing BGI-GBI Biotech Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Beijing Mabworks Biotech Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Beijing Syngentech Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Bellicum Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Benhealth Biopharmaceutical (Shenzhen) Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Betta Pharmaceuticals Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Bio-Thera Solutions Ltd, H2 2019
  • Gastric Cancer - Pipeline by BioIntegrator Ltd, H2 2019
  • Gastric Cancer - Pipeline by BioLineRx Ltd, H2 2019
  • Gastric Cancer - Pipeline by BioMed Valley Discoveries Inc, H2 2019
  • Gastric Cancer - Pipeline by Biosion Inc, H2 2019
  • Gastric Cancer - Pipeline by Biotecnol Ltd, H2 2019
  • Gastric Cancer - Pipeline by Boehringer Ingelheim International GmbH, H2 2019
  • Gastric Cancer - Pipeline by Boston Biomedical Inc, H2 2019
  • Gastric Cancer - Pipeline by Bristol-Myers Squibb Co, H2 2019
  • Gastric Cancer - Pipeline by CalyGene Biotechnology Inc, H2 2019
  • Gastric Cancer - Pipeline by Camel-IDS NV, H2 2019
  • Gastric Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by CARsgen Therapeutics Ltd, H2 2019
  • Gastric Cancer - Pipeline by CAS-Lamvac Biotech Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Catalent Inc, H2 2019
  • Gastric Cancer - Pipeline by Celgene Corp, H2 2019
  • Gastric Cancer - Pipeline by Celldex Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Cellestia Biotech AG, H2 2019
  • Gastric Cancer - Pipeline by Cellid Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Cellivery Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Cello Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Cellular Biomedicine Group Inc, H2 2019
  • Gastric Cancer - Pipeline by Celon Pharma SA, H2 2019
  • Gastric Cancer - Pipeline by Chia Tai Tianqing Pharmaceutical Group Co Ltd., H2 2019
  • Gastric Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2019
  • Gastric Cancer - Pipeline by Chugai Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by CMG Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Coherent Biopharma, H2 2019
  • Gastric Cancer - Pipeline by Convalife, H2 2019
  • Gastric Cancer - Pipeline by Cristal Therapeutics BV, H2 2019
  • Gastric Cancer - Pipeline by CSPC Pharmaceutical Group Ltd, H2 2019
  • Gastric Cancer - Pipeline by CStone Pharmaceuticals Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Cumberland Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Curegenix Inc, H2 2019
  • Gastric Cancer - Pipeline by CureLab Oncology Inc, H2 2019
  • Gastric Cancer - Pipeline by CureMeta LLC, H2 2019
  • Gastric Cancer - Pipeline by Cynvec LLC, H2 2019
  • Gastric Cancer - Pipeline by Cytocom Inc, H2 2019
  • Gastric Cancer - Pipeline by Cytodyn Inc, H2 2019
  • Gastric Cancer - Pipeline by CytoMed Therapeutics Pte Ltd, H2 2019
  • Gastric Cancer - Pipeline by CytomX Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Daiichi Sankyo Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Delta-Fly Pharma Inc, H2 2019
  • Gastric Cancer - Pipeline by DiNonA Inc, H2 2019
  • Gastric Cancer - Pipeline by DM Bio Ltd, H2 2019
  • Gastric Cancer - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2019
  • Gastric Cancer - Pipeline by DrugCendR Inc, H2 2019
  • Gastric Cancer - Pipeline by Eddingpharm Inc, H2 2019
  • Gastric Cancer - Pipeline by eFFECTOR Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by EirGenix Inc, H2 2019
  • Gastric Cancer - Pipeline by Eisai Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Eli Lilly and Co, H2 2019
  • Gastric Cancer - Pipeline by EOS Biosciences Inc, H2 2019
  • Gastric Cancer - Pipeline by Erytech Pharma SA, H2 2019
  • Gastric Cancer - Pipeline by Esperance Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Eutilex Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Exelixis Inc, H2 2019
  • Gastric Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H2 2019
  • Gastric Cancer - Pipeline by F1 Oncology Inc, H2 2019
  • Gastric Cancer - Pipeline by Faron Pharmaceuticals Oy, H2 2019
  • Gastric Cancer - Pipeline by Fate Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Five Prime Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Frost Biologic Inc, H2 2019
  • Gastric Cancer - Pipeline by G+FLAS Life Sciences Inc, H2 2019
  • Gastric Cancer - Pipeline by GEMoaB Monoclonals GmbH, H2 2019
  • Gastric Cancer - Pipeline by Geneius Biotechnology Inc, H2 2019
  • Gastric Cancer - Pipeline by Genentech Inc, H2 2019
  • Gastric Cancer - Pipeline by GeneScience Pharmaceuticals Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Genmab A/S, H2 2019
  • Gastric Cancer - Pipeline by Gilead Sciences Inc, H2 2019
  • Gastric Cancer - Pipeline by GlaxoSmithKline Plc, H2 2019
  • Gastric Cancer - Pipeline by GLG Pharma SA, H2 2019
  • Gastric Cancer - Pipeline by GlycoNex Inc, H2 2019
  • Gastric Cancer - Pipeline by Glycotope GmbH, H2 2019
  • Gastric Cancer - Pipeline by Good T Cells Inc, H2 2019
  • Gastric Cancer - Pipeline by Gossamer Bio Inc, H2 2019
  • Gastric Cancer - Pipeline by Green Cross LabCell Corp, H2 2019
  • Gastric Cancer - Pipeline by Grid Therapeutics LLC, H2 2019
  • Gastric Cancer - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Hangzhou DAC Biotech Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Harbin Gloria Pharmaceuticals Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Harbour BioMed, H2 2019
  • Gastric Cancer - Pipeline by Hengenix Biotech Inc, H2 2019
  • Gastric Cancer - Pipeline by HengRui YuanZheng Bio-Technology Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Hope Biosciences Inc, H2 2019
  • Gastric Cancer - Pipeline by Horizon Therapeutics PLC, H2 2019
  • Gastric Cancer - Pipeline by Hummingbird Bioscience Pte Ltd, H2 2019
  • Gastric Cancer - Pipeline by Hutchison MediPharma Ltd, H2 2019
  • Gastric Cancer - Pipeline by I-Mab Biopharma Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Ichnos Sciences Inc, H2 2019
  • Gastric Cancer - Pipeline by Igem Therapeutics Ltd, H2 2019
  • Gastric Cancer - Pipeline by Ildong Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Immunicum AB, H2 2019
  • Gastric Cancer - Pipeline by Immunocore Ltd, H2 2019
  • Gastric Cancer - Pipeline by Immunomedics Inc, H2 2019
  • Gastric Cancer - Pipeline by Immunomet Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Immunomic Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Imugene Ltd, H2 2019
  • Gastric Cancer - Pipeline by Incyte Corp, H2 2019
  • Gastric Cancer - Pipeline by Inhibrx Inc, H2 2019
  • Gastric Cancer - Pipeline by InnoCare Pharma Ltd, H2 2019
  • Gastric Cancer - Pipeline by Innovative Cellular Therapeutics Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Innovent Biologics Inc, H2 2019
  • Gastric Cancer - Pipeline by Inovio Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Intezyne Inc, H2 2019
  • Gastric Cancer - Pipeline by Intra-Immusg Pvt Ltd, H2 2019
  • Gastric Cancer - Pipeline by Ipsen SA, H2 2019
  • Gastric Cancer - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by JHL Biotech Inc, H2 2019
  • Gastric Cancer - Pipeline by Jiangsu Alphamab Biopharmaceuticals Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Jiangsu Atom Bioscience and Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Jiuzhitang Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Johnson & Johnson, H2 2019
  • Gastric Cancer - Pipeline by Jounce Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by JW Pharmaceutical Corp, H2 2019
  • Gastric Cancer - Pipeline by Kazia Therapeutics Ltd, H2 2019
  • Gastric Cancer - Pipeline by KLUS Pharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Komipharm International Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Konruns Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Kringle Pharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Kymab Ltd, H2 2019
  • Gastric Cancer - Pipeline by Kyowa Kirin Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by LATITUDE Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by LegoChem Biosciences Inc, H2 2019
  • Gastric Cancer - Pipeline by Lepu Medical Technology (Beijing) Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Mabpharm Ltd, H2 2019
  • Gastric Cancer - Pipeline by MacroGenics Inc, H2 2019
  • Gastric Cancer - Pipeline by MaxiVAX SA, H2 2019
  • Gastric Cancer - Pipeline by MBQ Pharma Inc, H2 2019
  • Gastric Cancer - Pipeline by MedAbome Inc, H2 2019
  • Gastric Cancer - Pipeline by Meditope Biosciences Inc, H2 2019
  • Gastric Cancer - Pipeline by MedPacto Inc, H2 2019
  • Gastric Cancer - Pipeline by Merck & Co Inc, H2 2019
  • Gastric Cancer - Pipeline by Merck KGaA, H2 2019
  • Gastric Cancer - Pipeline by Merus NV, H2 2019
  • Gastric Cancer - Pipeline by Metagone Biotech Inc, H2 2019
  • Gastric Cancer - Pipeline by Metis Precision Medicine, H2 2019
  • Gastric Cancer - Pipeline by Millennium Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2019
  • Gastric Cancer - Pipeline by Moderna Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Molecular Partners AG, H2 2019
  • Gastric Cancer - Pipeline by Molecular Templates Inc, H2 2019
  • Gastric Cancer - Pipeline by Moleculin Biotech LLC, H2 2019
  • Gastric Cancer - Pipeline by Mustang Bio Inc, H2 2019
  • Gastric Cancer - Pipeline by Mycenax Biotech Inc, H2 2019
  • Gastric Cancer - Pipeline by Nanjing Legend Biotech Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Nanjing Sanhome Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Nanjing Tianyi Bioscience Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by NanoCarrier Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by NBE-Therapeutics AG, H2 2019
  • Gastric Cancer - Pipeline by NeuClone Pty Ltd, H2 2019
  • Gastric Cancer - Pipeline by NewBio Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by NGM Biopharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Nouscom AG, H2 2019
  • Gastric Cancer - Pipeline by Novartis AG, H2 2019
  • Gastric Cancer - Pipeline by Novonco Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by OBI Pharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Ona Therapeutics SL, H2 2019
  • Gastric Cancer - Pipeline by OncoImmune Inc, H2 2019
  • Gastric Cancer - Pipeline by Oncologie Inc, H2 2019
  • Gastric Cancer - Pipeline by Oncolys BioPharma Inc, H2 2019
  • Gastric Cancer - Pipeline by OncoMed Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by OncoSynergy Inc, H2 2019
  • Gastric Cancer - Pipeline by OncoTherapy Science Inc, H2 2019
  • Gastric Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Onxeo SA, H2 2019
  • Gastric Cancer - Pipeline by Opsona Therapeutics Ltd, H2 2019
  • Gastric Cancer - Pipeline by Orano Med LLC, H2 2019
  • Gastric Cancer - Pipeline by Oxford BioTherapeutics Ltd, H2 2019
  • Gastric Cancer - Pipeline by Patrys Ltd, H2 2019
  • Gastric Cancer - Pipeline by Peptron Inc, H2 2019
  • Gastric Cancer - Pipeline by PersonGen Biomedicine Suzhou Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Pfizer Inc, H2 2019
  • Gastric Cancer - Pipeline by Phanes Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Pharma Mar SA, H2 2019
  • Gastric Cancer - Pipeline by Pharmapraxis, H2 2019
  • Gastric Cancer - Pipeline by Phosplatin Therapeutics LLC, H2 2019
  • Gastric Cancer - Pipeline by Pieris Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Plus Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by PNB Vesper Life Science Pvt Ltd, H2 2019
  • Gastric Cancer - Pipeline by Polaris Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Prescient Therapeutics Ltd, H2 2019
  • Gastric Cancer - Pipeline by Prestige BioPharma Pte Ltd, H2 2019
  • Gastric Cancer - Pipeline by ProLynx LLC, H2 2019
  • Gastric Cancer - Pipeline by Puma Biotechnology Inc, H2 2019
  • Gastric Cancer - Pipeline by QED Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Rakuten Medical Inc, H2 2019
  • Gastric Cancer - Pipeline by RAPT Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by RaQualia Pharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Redx Pharma Plc, H2 2019
  • Gastric Cancer - Pipeline by RemeGen Ltd, H2 2019
  • Gastric Cancer - Pipeline by Rhizen Pharmaceuticals SA, H2 2019
  • Gastric Cancer - Pipeline by Richter Gedeon Nyrt, H2 2019
  • Gastric Cancer - Pipeline by RUS Pharmtech, H2 2019
  • Gastric Cancer - Pipeline by Samumed LLC, H2 2019
  • Gastric Cancer - Pipeline by Samyang Holdings Corp, H2 2019
  • Gastric Cancer - Pipeline by Sanofi, H2 2019
  • Gastric Cancer - Pipeline by Sapvax LLC, H2 2019
  • Gastric Cancer - Pipeline by Scancell Holdings Plc, H2 2019
  • Gastric Cancer - Pipeline by Seattle Genetics Inc, H2 2019
  • Gastric Cancer - Pipeline by SELLAS Life Sciences Group Inc, H2 2019
  • Gastric Cancer - Pipeline by Shandong Boan Biological Technology Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Shanghai Biomed-Union Biotechnology Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Shanghai GeneChem Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Shanghai Haihe Biopharma Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Shanghai Henlius Biotech Inc, H2 2019
  • Gastric Cancer - Pipeline by Shanghai Miracogen Inc, H2 2019
  • Gastric Cancer - Pipeline by Shanghai Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Shenzhen BinDeBio Ltd, H2 2019
  • Gastric Cancer - Pipeline by Shenzhen Fapon Biopharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Shenzhen Hornetcorn Bio-technology Company Ltd, H2 2019
  • Gastric Cancer - Pipeline by Shionogi & Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Siena Biotech SpA, H2 2019
  • Gastric Cancer - Pipeline by Sillajen Biotherapeutics, H2 2019
  • Gastric Cancer - Pipeline by Simcere Pharmaceutical Group, H2 2019
  • Gastric Cancer - Pipeline by Sino Biopharmaceutical Ltd, H2 2019
  • Gastric Cancer - Pipeline by Sinocelltech Ltd, H2 2019
  • Gastric Cancer - Pipeline by SN BioScience, H2 2019
  • Gastric Cancer - Pipeline by Sorrento Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Sound Biologics, H2 2019
  • Gastric Cancer - Pipeline by Spring Bank Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Stemirna Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by StemMed Ltd, H2 2019
  • Gastric Cancer - Pipeline by Suntec Medical (Taiwan) Inc, H2 2019
  • Gastric Cancer - Pipeline by Supratek Pharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Suzhou Zelgen Biopharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by SynCore Biotechnology Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Synthon Holdings BV, H2 2019
  • Gastric Cancer - Pipeline by Taiho Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Takis Srl, H2 2019
  • Gastric Cancer - Pipeline by Tarveda Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Tasly Pharmaceutical Group Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H2 2019
  • Gastric Cancer - Pipeline by Tonix Pharmaceuticals Inc, H2 2019
  • Gastric Cancer - Pipeline by Toray Industries Inc, H2 2019
  • Gastric Cancer - Pipeline by TOT Biopharm Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Treos Bio Ltd, H2 2019
  • Gastric Cancer - Pipeline by Trio Medicines Ltd, H2 2019
  • Gastric Cancer - Pipeline by Triumvira Immunologics Inc, H2 2019
  • Gastric Cancer - Pipeline by Turning Point Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Turnstone Biologics Inc, H2 2019
  • Gastric Cancer - Pipeline by Tvardi Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Tyg Oncology Ltd, H2 2019
  • Gastric Cancer - Pipeline by Ube Industries Ltd, H2 2019
  • Gastric Cancer - Pipeline by United BioPharma Inc, H2 2019
  • Gastric Cancer - Pipeline by Unum Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Vaxon Biotech, H2 2019
  • Gastric Cancer - Pipeline by Venus Remedies Ltd, H2 2019
  • Gastric Cancer - Pipeline by Viracta Therapeutics Inc, H2 2019
  • Gastric Cancer - Pipeline by Viral Gene Inc, H2 2019
  • Gastric Cancer - Pipeline by Well Marker Bio Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Wuhan Binhui Biotechnology Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Wuhan YZY Biopharma Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Xcovery Holding Company LLC, H2 2019
  • Gastric Cancer - Pipeline by Xencor Inc, H2 2019
  • Gastric Cancer - Pipeline by Xiangxue Life Sciences, H2 2019
  • Gastric Cancer - Pipeline by XuanZhu Pharma Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Zai Lab Ltd, H2 2019
  • Gastric Cancer - Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Zhejiang Jianfeng Group Company Ltd, H2 2019
  • Gastric Cancer - Pipeline by Zhengda Tianqing Kangfang Shanghai Biomedical Technology Co Ltd, H2 2019
  • Gastric Cancer - Pipeline by Zymeworks Inc, H2 2019
  • Gastric Cancer - Dormant Projects, H2 2019
  • Gastric Cancer - Discontinued Products, H2 2019

List of Figures

  • Number of Products under Development for Gastric Cancer, H2 2019
  • Number of Products under Development by Companies, H2 2019
  • Number of Products under Development by Universities/Institutes, H2 2019
  • Number of Products by Top 10 Targets, H2 2019
  • Number of Products by Stage and Top 10 Targets, H2 2019
  • Number of Products by Top 10 Mechanism of Actions, H2 2019
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
  • Number of Products by Top 10 Routes of Administration, H2 2019
  • Number of Products by Stage and Top 10 Routes of Administration, H2 2019
  • Number of Products by Top 10 Molecule Types, H2 2019
  • Number of Products by Stage and Top 10 Molecule Types, H2 2019
Back to Top